Basics Adaptive Biotechnologies Corporation IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.25B Activated in VL: True Average Daily Range Avg Daily Range: $0.61 | 3.29% Avg Daily Range (30 D): $0.57 | 3.40% Avg Daily Range (90 D): $0.44 | 3.00% Institutional Daily Volume Avg Daily Volume: 1.08M Avg Daily Volume (30 D): 2.08M Avg Daily Volume (90 D): 1.82M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 2,766 Avg Inst. Trade: $1.92M Avg Inst. Trade (30 D): $2.03M Avg Inst. Trade (90 D): $2.33M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.38M Avg Closing Trade (30 D): $3.75M Avg Closing Trade (90 D): $3.46M Avg Closing Volume: 145.17K     News Dec 6, 2025 @ 1:30 PM Adaptive Biotechnologies Showcases Leadership in H... Source: Adaptive Biotechnologies Corporation Dec 5, 2025 @ 6:33 PM Why Is Adaptive Biotechnologies Stock Trading Lowe... Source: Vandana Singh Aug 6, 2025 @ 11:01 PM Why Adaptive Biotechnologies Stock Popped by Almos... Source: Eric Volkman Jul 25, 2025 @ 8:59 AM U.S. Minimal Residual Disease Testing Market Trend... Source: Researchandmarkets.Com May 30, 2025 @ 11:30 AM Adaptive Biotechnologies Highlights New Data at 20... Source: Adaptive Biotechnologies Corporation Financials   TTM Q3 2025 Q2 2025 Basic EPS $.06 $-.17 Diluted EPS $.06 $-.17 Revenue $ $ 93.97M $ 58.88M Gross Profit $ $ 75.82M $ 40.88M Net Income / Loss $ $ 9.55M $ -25.59M Operating Income / Loss $ $ 10.29M $ -25.04M Cost of Revenue $ $ 18.16M $ 18M Net Cash Flow $ $ 11.84M $ -7.47M PE Ratio